Procter & Gamble Health Limited

BSE: 500126 NSE: PGHL
Procter & Gamble Health Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L99999MH1967PLC013726 Incorporated 26 April 1967 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: PGHL · BSE: 500126 Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2026
₹1,407.97 Cr
▲ 50.72% YoY
Computed EBITDA · FY 2026
₹474 Cr
▲ 44.19% YoY
Net profit · FY 2026
₹326.91 Cr
▲ 39.46% YoY
Authorised capital
₹18 Cr
Registered with MCA
Paid-up capital
₹16.6 Cr
Issued & subscribed
Open charges
None
Satisfied ₹41 Cr
Company age
59 yrs
Est. 1967
Employees · EPFO
1,420
Latest available

About Procter & Gamble Health Limited

Data last updated: 13 July 2026

Procter & Gamble Health Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Procter & Gamble Overseas India Bv. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 26 April 1967, the company has been in operation for over 59 years.

Registered with ROC Mumbai under CIN L99999MH1967PLC013726. Listed on BSE: 500126 and NSE: PGHL.

Capital: an authorised share capital of ₹18 Cr and a paid-up capital of ₹16.6 Cr. Formerly known as Merck Limited and E.Merck (I) P Ltd. It is led by directors including Milind Vasant Thatte and Aalok Agrawal.

Last AGM: 29 August 2025. Financial statements filed for year ended 31 March 2025. Office: P & G Plaza Cardinal Gracias Road Chakala Andheri East, Mumbai, Maharashtra, India – 400099.

As per NSE-filed standalone financials for FY 2026, the company reported a revenue of ₹1,407.97 Cr, a growth of 50.72% compared to the previous year. The net worth stands at ₹524.55 Cr (down 2.31% YoY). Total assets are valued at ₹841.35 Cr (up 5.94% YoY).

The company has a workforce of approximately 1,420 employees as per the latest available data. It operates as a subsidiary of Procter & Gamble Overseas India Bv.

The company is associated with 2 brands - Procter & Gamble Health, Mckinsey. As per MCA filings, the company has satisfied charges of ₹41 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pghealthindia.com.

Company Details of Procter & Gamble Health Limited
CIN L99999MH1967PLC013726
Registration Number 013726
Incorporation Date 26 April 1967
ROC Mumbai
Listing Status Listed (BSE: 500126, NSE: PGHL)
Company Status Active
Date of Last AGM 29 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Procter & Gamble Overseas India Bv
Compliance Status Active Compliant
Key People
Milind Vasant Thatte Managing Director Shashank Raghupathy Srowthy Whole-Time Director Aalok Agrawal Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    pghealthindia.com
  • Social Media
    Locked
  • Registered Address
    P & G Plaza Cardinal Gracias Road Chakala Andheri East, Mumbai, Maharashtra, India – 400099
  • Industry
    Chemicals and Materials, Industrial Chemicals
Company report
Procter & Gamble Health Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Procter & Gamble Health Limited report

Financials, compliance, directors, charges, ownership and filings for Procter & Gamble Health Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Procter & Gamble Health Limited

Procter & Gamble Health Limited has undergone 2 name changes throughout its history. The company was previously known as Merck Limited, and E.Merck (I) P Ltd. The current legal name is Procter & Gamble Health Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Procter & Gamble Health Limited Current
Merck Limited Previous
E.Merck (I) P Ltd Previous

Associated Brands with Procter & Gamble Health Limited

Procter & Gamble Health Limited operates two associated brands: Procter & Gamble Health and McKinsey. These brands represent Procter & Gamble Health Limited's diversified market presence and brand portfolio.

Brand Description Website
Procter & Gamble Health
Manufacturer of OTC, vitamin & mineral supplements, and chemical products pghealthindia.com
McKinsey
Global management consulting is provided to businesses and governments. mckinsey.com

Competitors & Alternatives of Procter & Gamble Health Limited

Brands and companies operating in the same space as Procter & Gamble Health Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
Booz Allen Hamilton Booz Allen Hamilton Analytics, cybersecurity, and digital transformation services are provided. Mclean, United States, United States 1914
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Cyient Cyient Provider of digital engineering and technology services Hyderabad, India, India 1991
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007

Auditor Details of Procter & Gamble Health Limited

Procter & Gamble Health Limited is audited by Haribhakti & Co LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Haribhakti & Co LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Procter & Gamble Health Limited

Procter & Gamble Health Limited is currently managed by 7 directors, with 34 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Milind Vasant Thatte Managing Director 01 Apr 2018 8 Years 3 Months Current
Aalok Agrawal Director 01 Jun 2019 7 Years 1 Months Current
Subramanian Madhavan
Also directs: Anthem Biosciences Limited, Eicher Motors Limited, Welspun Enterprises Limited and 4 more
Director 15 Nov 2021 4 Years 8 Months Current
Shashank Raghupathy Srowthy Whole-Time Director 01 Oct 2025 0 Years 9 Months Current
Krishna Sarma
Also directs: Meera Women Weavers Association, Virago Media Private Limited, Mango Care Foundation
Director 01 Apr 2025 1 Years 3 Months Current
Sharad Tyagi
Also directs: Iol Chemicals And Pharmaceuticals Limited
Director 01 Apr 2025 1 Years 3 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Procter & Gamble Health Limited FY 2026 filings available

Procter & Gamble Health Limited reported revenue of ₹1,407.97 Cr (up 50.72% YoY) for FY 2026.

Revenue · FY 2026
₹1,407.97 Cr ▲ 50.72%
Profit · FY 2026
₹326.91 Cr ▲ 39.46%
Computed EBITDA · FY 2026
₹474 Cr ▲ 44.19%
Revenue₹ Cr · Standalone05001,0001,500FY 2021: ₹1,009 Cr1,009FY 2021FY 2022: ₹1,114 Cr · +10.5% YoY1,114+10.5%FY 2022FY 2023: ₹1,230 Cr · +10.3% YoY1,230+10.3%FY 2023FY 2024: ₹1,151 Cr · -6.4% YoY1,151-6.4%FY 2024FY 2025: ₹934 Cr · -18.9% YoY934-18.9%FY 2025FY 2026: ₹1,408 Cr · +50.7% YoY1,408+50.7%FY 2026
Net Profit₹ Cr · Standalone0200400FY 2021: ₹177 Cr177FY 2021FY 2022: ₹193 Cr · +8.9% YoY193+8.9%FY 2022FY 2023: ₹229 Cr · +19.2% YoY229+19.2%FY 2023FY 2024: ₹201 Cr · -12.4% YoY201-12.4%FY 2024FY 2025: ₹234 Cr · +16.6% YoY234+16.6%FY 2025FY 2026: ₹327 Cr · +39.5% YoY327+39.5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400Q1'25: ₹284 Cr · -5.7% YoY284-5.7%Q1'25Q2'25: ₹313 Cr · +2.8% YoY313+2.8%Q2'25Q3'25: ₹310 Cr · -0.1% YoY310-0.1%Q3'25Q4'25: ₹311 Cr · +23.2% YoY311+23.2%Q4'25Q1'26: ₹339 Cr · +19.3% YoY339+19.3%Q1'26Q2'26: ₹325 Cr · +3.7% YoY325+3.7%Q2'26Q3'26: ₹374 Cr · +20.7% YoY374+20.7%Q3'26Q4'26: ₹370 Cr · +19.1% YoY370+19.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹1,407.97 Cr ₹934.17 Cr ₹1,151.26 Cr ₹1,229.62 Cr ₹1,114.41 Cr ₹1,008.73 Cr
Other Income ₹17.34 Cr ₹10.35 Cr ₹15.63 Cr ₹18.39 Cr ₹13.19 Cr ₹18.1 Cr
Total Income ₹1,425.31 Cr ₹944.52 Cr ₹1,166.89 Cr ₹1,248.01 Cr ₹1,127.6 Cr ₹1,026.83 Cr
Cost of Materials Consumed ₹307.33 Cr ₹200.59 Cr ₹290.23 Cr ₹319.23 Cr ₹323.72 Cr ₹289.12 Cr
Purchases of Stock-in-Trade ₹70.58 Cr ₹47.16 Cr ₹39.46 Cr ₹39.76 Cr ₹20.83 Cr ₹21.16 Cr
Changes in Inventories -₹12.83 Cr ₹14.75 Cr ₹87 Lakh ₹2.85 Cr -₹4.75 Cr ₹4.54 Cr
Employee Benefit Expense ₹222.56 Cr ₹142.06 Cr ₹215.16 Cr ₹206.17 Cr ₹167.56 Cr ₹150.47 Cr
Finance Costs ₹55 Lakh ₹43 Lakh ₹72 Lakh ₹77 Lakh ₹42 Lakh ₹80 Lakh
Depreciation & Amortisation ₹23.59 Cr ₹16.69 Cr ₹27.4 Cr ₹27.37 Cr ₹27.81 Cr ₹30.04 Cr
Other Expenses ₹363.67 Cr ₹211.22 Cr ₹299.54 Cr ₹337.66 Cr ₹338.64 Cr ₹297.42 Cr
Total Expenses ₹975.45 Cr ₹632.9 Cr ₹873.38 Cr ₹933.81 Cr ₹874.23 Cr ₹793.55 Cr
Profit Before Exceptional Items & Tax ₹449.86 Cr ₹311.62 Cr ₹293.51 Cr ₹314.2 Cr ₹253.37 Cr ₹233.28 Cr
Exceptional Items ₹0 ₹0 -₹20.19 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹449.86 Cr ₹311.62 Cr ₹273.32 Cr ₹314.2 Cr ₹253.37 Cr ₹233.28 Cr
Total Tax Expense ₹122.95 Cr ₹77.21 Cr ₹72.34 Cr ₹84.73 Cr ₹60.85 Cr ₹56.48 Cr
Net Profit ₹326.91 Cr ₹234.41 Cr ₹200.98 Cr ₹229.47 Cr ₹192.52 Cr ₹176.8 Cr
Other Comprehensive Income -₹28 Lakh -₹2.62 Cr ₹67 Lakh -₹1.84 Cr ₹70 Lakh ₹42 Lakh
Total Comprehensive Income ₹326.63 Cr ₹231.79 Cr ₹201.65 Cr ₹227.63 Cr ₹193.22 Cr ₹177.22 Cr
EBITDA (computed) ₹474 Cr ₹328.74 Cr ₹321.63 Cr ₹342.34 Cr ₹281.6 Cr ₹264.12 Cr
Basic EPS ₹196.94 ₹141.22 ₹121.07 ₹138.23 ₹116.00 ₹106.50
Diluted EPS ₹196.94 ₹141.22 ₹121.07 ₹138.23 ₹116.00 ₹106.50
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Total Assets ₹841.35 Cr ₹794.2 Cr ₹794.36 Cr ₹1,101.19 Cr ₹893.72 Cr
Non-current Assets ₹285.09 Cr ₹267.81 Cr ₹270.14 Cr ₹305.09 Cr ₹196.22 Cr
Current Assets ₹556.26 Cr ₹526.39 Cr ₹515.22 Cr ₹796.1 Cr ₹697.5 Cr
Property, Plant & Equipment ₹99.24 Cr ₹104.63 Cr ₹125.64 Cr ₹129.64 Cr ₹106.35 Cr
Inventories ₹136.65 Cr ₹109.37 Cr ₹109.11 Cr ₹134.94 Cr ₹115.21 Cr
Trade Receivables ₹164.26 Cr ₹145.4 Cr ₹85.33 Cr ₹115.71 Cr ₹83.44 Cr
Cash & Equivalents ₹177.24 Cr ₹182.08 Cr ₹238.5 Cr ₹435.05 Cr ₹319.4 Cr
Equity (Net Worth) ₹524.55 Cr ₹536.96 Cr ₹538.24 Cr ₹750.89 Cr ₹616.49 Cr
Equity Share Capital ₹16.6 Cr ₹16.6 Cr ₹16.6 Cr ₹16.6 Cr ₹16.6 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹0 ₹0 ₹0 ₹0 ₹0
Current Liabilities ₹254.93 Cr ₹215.31 Cr ₹218.91 Cr ₹303.9 Cr ₹235.83 Cr
Total Liabilities ₹316.8 Cr ₹257.24 Cr ₹256.12 Cr ₹350.3 Cr ₹277.23 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Operating Cash Flow ₹337.79 Cr ₹168.69 Cr ₹228.28 Cr ₹235.99 Cr ₹169.52 Cr ₹247.26 Cr
Investing Cash Flow ₹1.26 Cr ₹9.59 Cr -₹6.87 Cr -₹21.5 Cr -₹25.54 Cr -₹32.27 Cr
Financing Cash Flow -₹343.92 Cr -₹234.74 Cr -₹418.1 Cr -₹98.47 Cr -₹288.63 Cr -₹386.63 Cr
Capital Expenditure ₹15.51 Cr ₹0 ₹21.73 Cr ₹42.48 Cr ₹37.92 Cr ₹52.58 Cr
Free Cash Flow (computed) ₹322.28 Cr ₹168.69 Cr ₹206.55 Cr ₹193.51 Cr ₹131.6 Cr ₹194.68 Cr
Dividends Paid ₹340.28 Cr ₹232.4 Cr ₹414.99 Cr ₹93.79 Cr ₹283.85 Cr ₹381.78 Cr
Net Change in Cash -₹4.87 Cr -₹56.46 Cr -₹196.69 Cr ₹116.02 Cr -₹144.65 Cr -₹171.64 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹370.45 Cr ₹373.86 Cr ₹324.92 Cr ₹338.74 Cr ₹310.99 Cr ₹309.77 Cr ₹313.41 Cr ₹283.88 Cr ₹252.48 Cr ₹309.97 Cr ₹304.93 Cr ₹301.18 Cr
Other Income ₹4 Cr ₹4.36 Cr ₹4.95 Cr ₹4.03 Cr ₹3.11 Cr ₹3.96 Cr ₹3.28 Cr ₹2.13 Cr ₹2.27 Cr ₹5.18 Cr ₹6.05 Cr ₹5.46 Cr
Total Income ₹374.45 Cr ₹378.22 Cr ₹329.87 Cr ₹342.77 Cr ₹314.1 Cr ₹313.73 Cr ₹316.69 Cr ₹286.01 Cr ₹254.75 Cr ₹315.15 Cr ₹310.98 Cr ₹306.64 Cr
Cost of Materials Consumed ₹85.19 Cr ₹84.47 Cr ₹78.13 Cr ₹59.54 Cr ₹90.82 Cr ₹61.6 Cr ₹48.17 Cr ₹67.42 Cr ₹64.66 Cr ₹70.84 Cr ₹87.31 Cr ₹74.31 Cr
Purchases of Stock-in-Trade ₹22.31 Cr ₹13.32 Cr ₹10.64 Cr ₹24.31 Cr ₹13.72 Cr ₹13.28 Cr ₹20.16 Cr ₹18.51 Cr ₹11.13 Cr ₹8.4 Cr ₹1.42 Cr ₹6.38 Cr
Changes in Inventories -₹14.63 Cr ₹12.03 Cr -₹20.37 Cr ₹10.14 Cr -₹5.82 Cr ₹85 Lakh ₹19.72 Cr -₹6.76 Cr -₹1.93 Cr ₹11.15 Cr -₹1.59 Cr ₹13.18 Cr
Employee Benefit Expense ₹50.86 Cr ₹61.81 Cr ₹53.88 Cr ₹56.01 Cr ₹48.79 Cr ₹47.05 Cr ₹46.22 Cr ₹48.63 Cr ₹48.46 Cr ₹57.43 Cr ₹60.64 Cr ₹55.4 Cr
Finance Costs ₹21 Lakh ₹10 Lakh ₹12 Lakh ₹12 Lakh ₹13 Lakh ₹15 Lakh ₹15 Lakh ₹20 Lakh ₹15 Lakh ₹19 Lakh ₹18 Lakh ₹17 Lakh
Depreciation & Amortisation ₹6.17 Cr ₹5.9 Cr ₹6.08 Cr ₹5.44 Cr ₹5.37 Cr ₹5.55 Cr ₹5.77 Cr ₹7.16 Cr ₹6.84 Cr ₹6.92 Cr ₹6.48 Cr ₹6.38 Cr
Other Expenses ₹91.13 Cr ₹91.77 Cr ₹82.37 Cr ₹98.4 Cr ₹82.56 Cr ₹63.56 Cr ₹65.1 Cr ₹107.83 Cr ₹62.72 Cr ₹60.5 Cr ₹68.49 Cr ₹106.69 Cr
Total Expenses ₹241.24 Cr ₹269.4 Cr ₹210.85 Cr ₹253.96 Cr ₹235.57 Cr ₹192.04 Cr ₹205.29 Cr ₹242.99 Cr ₹192.03 Cr ₹215.43 Cr ₹222.93 Cr ₹262.51 Cr
Profit Before Exceptional Items & Tax ₹133.21 Cr ₹108.82 Cr ₹119.02 Cr ₹88.81 Cr ₹78.53 Cr ₹121.69 Cr ₹111.4 Cr ₹43.02 Cr ₹62.72 Cr ₹99.72 Cr ₹88.05 Cr ₹44.13 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹20.19 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹133.21 Cr ₹108.82 Cr ₹119.02 Cr ₹88.81 Cr ₹78.53 Cr ₹121.69 Cr ₹111.4 Cr ₹22.83 Cr ₹62.72 Cr ₹99.72 Cr ₹88.05 Cr ₹44.13 Cr
Total Tax Expense ₹38.61 Cr ₹31.23 Cr ₹30.48 Cr ₹22.63 Cr ₹17.35 Cr ₹30.79 Cr ₹29.07 Cr ₹6.05 Cr ₹16.16 Cr ₹27.65 Cr ₹22.48 Cr ₹14.31 Cr
Net Profit ₹94.6 Cr ₹77.59 Cr ₹88.54 Cr ₹66.18 Cr ₹61.18 Cr ₹90.9 Cr ₹82.33 Cr ₹16.78 Cr ₹46.56 Cr ₹72.07 Cr ₹65.57 Cr ₹29.82 Cr
Other Comprehensive Income -₹2.93 Cr ₹88 Lakh ₹2.42 Cr -₹65 Lakh -₹80 Lakh -₹1.99 Cr ₹17 Lakh -₹1.01 Cr ₹1.33 Cr ₹86 Lakh -₹51 Lakh ₹44 Lakh
Total Comprehensive Income ₹91.67 Cr ₹78.47 Cr ₹90.96 Cr ₹65.53 Cr ₹60.38 Cr ₹88.91 Cr ₹82.5 Cr ₹15.77 Cr ₹47.89 Cr ₹72.93 Cr ₹65.06 Cr ₹30.26 Cr
EBITDA (computed) ₹139.59 Cr ₹114.82 Cr ₹125.22 Cr ₹94.37 Cr ₹84.03 Cr ₹127.39 Cr ₹117.32 Cr ₹50.38 Cr ₹69.71 Cr ₹106.83 Cr ₹94.71 Cr ₹50.68 Cr
Basic EPS ₹56.99 ₹46.74 ₹53.34 ₹39.87 ₹36.86 ₹54.76 ₹49.60 ₹10.11 ₹28.00 ₹43.40 ₹39.50 ₹17.96
Diluted EPS ₹56.99 ₹46.74 ₹53.34 ₹39.87 ₹36.86 ₹54.76 ₹49.60 ₹10.11 ₹28.00 ₹43.40 ₹39.50 ₹17.96
Latest 12 quarters shown of 23 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Procter & Gamble Health Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Procter & Gamble Health Limited

As per the shareholding pattern filed with NSE for the quarter ended Jun 2026, promoters hold 51.82%, foreign institutional investors hold 6.33%, domestic institutional investors hold 12.44%, retail and other public shareholders hold 29.42% of Procter & Gamble Health Limited. The company had 49,056 shareholders on record.

Promoters: 51.82%DII (Domestic Institutional): 12.44%FII (Foreign Institutional): 6.33%Retail & Others: 29.42%
Jun 2026
QUARTER
51.82% Promoters
12.44% DII (Domestic Institutional)
6.33% FII (Foreign Institutional)
29.42% Retail & Others
Promoter holding - history
Now 51.82% · Jun 2026High 51.82% · Dec 2018Low 51.80% · Dec 2015
50%50.8%51.5%52.3%53%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 51.80%Mar 2016: 51.80%Jun 2016: 51.80%Sep 2016: 51.80%Dec 2016: 51.80%Mar 2017: 51.80%Jun 2017: 51.80%Sep 2017: 51.80%Dec 2017: 51.80%Mar 2018: 51.80%Jun 2018: 51.80%Sep 2018: 51.80%Dec 2018: 51.82%Mar 2019: 51.82%Jun 2019: 51.82%Sep 2019: 51.82%Dec 2019: 51.82%Mar 2020: 51.82%Jun 2020: 51.82%Sep 2020: 51.82%Dec 2020: 51.82%Mar 2021: 51.82%Jun 2021: 51.82%Sep 2021: 51.82%Dec 2021: 51.82%Mar 2022: 51.82%Jun 2022: 51.82%Sep 2022: 51.82%Dec 2022: 51.82%Mar 2023: 51.82%Jun 2023: 51.82%Sep 2023: 51.82%Dec 2023: 51.82%Mar 2024: 51.82%Jun 2024: 51.82%Sep 2024: 51.82%Dec 2024: 51.82%Mar 2025: 51.82%Jun 2025: 51.82%Sep 2025: 51.82%Dec 2025: 51.82%Mar 2026: 51.82%Jun 2026: 51.82%51.82%51.80%51.82%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Promoters51.82%51.82%51.82%51.82%51.82%51.82%
Public48.18%48.18%48.18%48.18%48.18%48.18%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters51.82%51.82%51.82%51.82%51.82%51.82%51.82%51.82%51.80%51.80%51.80%
Public48.18%48.18%48.18%48.18%48.18%48.18%48.18%48.18%48.20%48.20%48.20%
Promoter change (YoY, %pts)+0.00+0.00+0.00+0.00+0.00+0.00+0.00+0.02+0.00+0.00-

Board & Governance of Procter & Gamble Health Limited

As per the corporate governance filing with NSE for the quarter ended 30-JUN-2026, the board of Procter & Gamble Health Limited has 7 directors - 3 independent and 2 executive. The board is chaired by Subramanian Madhavan.

DirectorPositionOn board sinceListed boards
Subramanian Madhavan Non-Executive - Independent Director · Chairperson 2021-11-15 5
Milind Thatte Executive Director · MD 2018-04-01 1
Shashank Srowthy Executive Director 2025-10-01 1
Aalok Agrawal Non-Executive - Non Independent Director 2019-06-01 1
Seema Sambasivan Non-Executive - Non Independent Director 2023-04-01 1
Krishna Sarma Non-Executive - Independent Director 2025-04-01 1
Sharad Tyagi Non-Executive - Independent Director 2025-04-01 2
Board Committees
CommitteeMembers
Audit Committee Krishna Sarma (Chairperson), Sharad Tyagi, Subramanian Madhavan, Milind Thatte
Nomination and remuneration committee Sharad Tyagi (Chairperson), Subramanian Madhavan, Aalok Agrawal
Stakeholders Relationship Committee Sharad Tyagi (Chairperson), Milind Thatte, Shashank Srowthy
Risk Management Committee Milind Thatte (Chairperson), Aalok Agrawal, Subramanian Madhavan, Shashank Srowthy
Corporate Social Responsibility Committee Milind Thatte (Chairperson), Krishna Sarma, Shashank Srowthy

Charges & Borrowings of Procter & Gamble Health Limited

Open charges
₹0
Satisfied charges
₹41 Cr
Breakdown by lending institutions
Canara Bank₹41.00 Cr
Latest charge details
DateLenderAmountStatus
06 Jul 1995 Canara Bank ₹41 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Procter & Gamble Health Limited

Procter & Gamble Health Limited has a workforce of 1,420 employees as of Apr 10, 2024.

Employee count
1,420
Active EPFO establishments
1
Employee growth
4.8%
Premium access

Employee and EPFO history for Procter & Gamble Health Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Procter & Gamble Health Limited

Premium access

GST registrations and filing compliance for Procter & Gamble Health Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Procter & Gamble Health Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Procter & Gamble Health Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Procter & Gamble Health Limited

Premium access

MSME payment history for Procter & Gamble Health Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Procter & Gamble Health Limited

Premium access

Corporate group structure for Procter & Gamble Health Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Procter & Gamble Health Limited

Premium access

MCA filings and documents for Procter & Gamble Health Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Procter & Gamble Health Limited

Directors
21 Oct 2025
Shashank Raghupathy Srowthy was appointed as a Cfo on 21 Oct 2025 & has been associated with this company since 8 months 29 days.
Directors
01 Oct 2025
Shashank Raghupathy Srowthy was appointed as a Whole-time director on 01 Oct 2025 & has been associated with this company since 9 months 19 days.
Activity
29 Aug 2025
Procter & Gamble Health Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records.
Directors
01 Apr 2025
Krishna Sarma was appointed as a Director on 01 Apr 2025 & has been associated with this company since 1 year 3 months.
Directors
01 Apr 2025
Sharad Tyagi was appointed as a Director on 01 Apr 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Procter & Gamble Health Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.

Recent News on Procter & Gamble Health Limited

PG Healths Nasivion Enters Asia Book of Records
11 Jan 2024 · Business Wire India

Frequently Asked Questions about Procter & Gamble Health Limited

Procter & Gamble Health Limited is an active public limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 26 April 1967 (59+ years old) and is registered under CIN L99999MH1967PLC013726. Listed on BSE: 500126 and NSE: PGHL. The company has 1,420 employees.

Procter & Gamble Health Limited reported revenue of ₹1,407.97 Cr for FY 2026 (up 50.72% YoY) based on standalone NSE filings.

The current directors of Procter & Gamble Health Limited are:

The primary industry of Procter & Gamble Health Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.

Yes. Procter & Gamble Health Limited is listed on both BSE (code: 500126) and NSE (symbol: PGHL).

Procter & Gamble Health Limited can be reached at the registered office: P & G Plaza Cardinal Gracias Road Chakala Andheri East, Mumbai, Maharashtra, India – 400099, or through the website pghealthindia.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available